Search research articles
Contact Us
Filters
Showing results (481-490 of 526) with videos related to
Page
of 53
Sort By:
Cancer Biology & Therapy
|
January 27, 2016
EBI-907, a novel BRAF(V600E) inhibitor, has potent oral anti-tumor activity and a broad kinase selectivity profile
Jiayin Zhang, Biao Lu, Dong Liu, et al.
JCI Insight
|
February 10, 2025
The AURKA inhibitor alters the immune microenvironment and enhances targeting B7-H3 immunotherapy in glioblastoma
Jinqiu Liu, Yuxuan Deng, Zhuonan Pu, et al.
Water Research
|
November 17, 2023
Quantitative SARS-CoV-2 exposure assessment for workers in wastewater treatment plants using Monte-Carlo simulation
Cheng Yan, Yi-Ning Hu, Zi-Cheng Gui, et al.
Molecular Ecology Resources
|
August 18, 2022
Genomic investigation of the Chinese alligator reveals wild-extinct genetic diversity and genomic consequences of their continuous decline
Shangchen Yang, Tianming Lan, Yi Zhang, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
February 16, 2013
Durable efficacy and safety of raltegravir versus efavirenz when combined with tenofovir/emtricitabine in treatment-naive HIV-1-infected patients: final 5-year results from STARTMRK
Jürgen K Rockstroh, Edwin DeJesus, Jeffrey L Lennox, et al.
Cell Death & Disease
|
October 5, 2019
The desmosomal cadherin desmoglein-3 acts as a keratinocyte anti-stress protein via suppression of p53
Ambreen Rehman, Yang Cai, Christian Hünefeld, et al.
Pharmaceuticals (Basel, Switzerland)
|
February 27, 2026
Novel Propofol Analogs: Design, Synthesis and Evaluation of Dihydrobenzofuran Derivatives as General Anesthetics
Jun-Jie Shi, Jia-Quan Feng, Yuan-Hai Zou, et al.
Mabs
|
July 2, 2019
Discovery of high affinity, pan-allelic, and pan-mammalian reactive antibodies against the myeloid checkpoint receptor SIRPα
Janet Sim, Jonathan T Sockolosky, Emma Sangalang, et al.
ACS Medicinal Chemistry Letters
|
February 19, 2021
Discovery of Hydroxyamidine Derivatives as Highly Potent, Selective Indoleamine-2,3-dioxygenase 1 Inhibitors
Fangfang Jin, Qiyue Hu, Hongbo Fei, et al.
Clinical and Translational Science
|
March 26, 2025
Comparison of Molnupiravir Exposure-Response Relationships for Virology Response and Mechanism of Action Biomarkers With Clinical Outcomes in Treatment of COVID-19
Akshita Chawla, Ruthie Birger, Brian M Maas, et al.
Page
of 53
Search research articles
Search
Showing results (481-490 of 526) with videos related to
Sort By:
Page
of 53
Cancer Biology & Therapy
|
January 27, 2016
EBI-907, a novel BRAF(V600E) inhibitor, has potent oral anti-tumor activity and a broad kinase selectivity profile
Jiayin Zhang, Biao Lu, Dong Liu, et al.
JCI Insight
|
February 10, 2025
The AURKA inhibitor alters the immune microenvironment and enhances targeting B7-H3 immunotherapy in glioblastoma
Jinqiu Liu, Yuxuan Deng, Zhuonan Pu, et al.
Water Research
|
November 17, 2023
Quantitative SARS-CoV-2 exposure assessment for workers in wastewater treatment plants using Monte-Carlo simulation
Cheng Yan, Yi-Ning Hu, Zi-Cheng Gui, et al.
Molecular Ecology Resources
|
August 18, 2022
Genomic investigation of the Chinese alligator reveals wild-extinct genetic diversity and genomic consequences of their continuous decline
Shangchen Yang, Tianming Lan, Yi Zhang, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
February 16, 2013
Durable efficacy and safety of raltegravir versus efavirenz when combined with tenofovir/emtricitabine in treatment-naive HIV-1-infected patients: final 5-year results from STARTMRK
Jürgen K Rockstroh, Edwin DeJesus, Jeffrey L Lennox, et al.
Cell Death & Disease
|
October 5, 2019
The desmosomal cadherin desmoglein-3 acts as a keratinocyte anti-stress protein via suppression of p53
Ambreen Rehman, Yang Cai, Christian Hünefeld, et al.
Pharmaceuticals (Basel, Switzerland)
|
February 27, 2026
Novel Propofol Analogs: Design, Synthesis and Evaluation of Dihydrobenzofuran Derivatives as General Anesthetics
Jun-Jie Shi, Jia-Quan Feng, Yuan-Hai Zou, et al.
Mabs
|
July 2, 2019
Discovery of high affinity, pan-allelic, and pan-mammalian reactive antibodies against the myeloid checkpoint receptor SIRPα
Janet Sim, Jonathan T Sockolosky, Emma Sangalang, et al.
ACS Medicinal Chemistry Letters
|
February 19, 2021
Discovery of Hydroxyamidine Derivatives as Highly Potent, Selective Indoleamine-2,3-dioxygenase 1 Inhibitors
Fangfang Jin, Qiyue Hu, Hongbo Fei, et al.
Clinical and Translational Science
|
March 26, 2025
Comparison of Molnupiravir Exposure-Response Relationships for Virology Response and Mechanism of Action Biomarkers With Clinical Outcomes in Treatment of COVID-19
Akshita Chawla, Ruthie Birger, Brian M Maas, et al.
Page
of 53